TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2784382

Group type: EXPERIMENTAL
Intervention: Continuous 0.60 ppm NO2 (n = 9)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Background 0.05 ppm NO2 with three 15‐min peaks of 2.0 ppm (n = 15)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Air exposure (control group)
Number of subjects: 24
Study: 1159128

Group type: EXPERIMENTAL
Intervention: Behavioural training (3 sessions of behavior rehearsal, modeling, and coaching)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assessment control group
Number of subjects: 0
Study: 31941527

Group type: EXPERIMENTAL
Intervention: Mailed fecal immunochemical test (FIT) kits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no mailed FIT kits)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mailed FIT intervention for persons of Asian descent
Number of subjects: 0
Study: 31975520

Group type: EXPERIMENTAL
Intervention: Emotional regulation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 60
Study: 30352894

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 833

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 833
Study: 27073832

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) therapy, 15 minutes of intermittent vibration, performed twice per week for three months.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (CON), continued normal activities.
Number of subjects: 31
Study: 25529351

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 40
Study: 22717796

Group type: EXPERIMENTAL
Intervention: Transvaginal video‐assisted cholecystectomy (TVC)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 128
Study: 20363089

Group type: EXPERIMENTAL
Intervention: Treatment of Addiction to Nicotine in Schizophrenia (TANS)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Medication Management (MM)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Both TANS and MM
Number of subjects: 87
Study: 18766258

Group type: EXPERIMENTAL
Intervention: PEGLip‐rFVIII‐FS reconstituted with 4.2 mg/kg of pegylated liposomes
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PEGLip‐rFVIII‐FS reconstituted with 12.6 mg/kg of pegylated liposomes
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PEGLip‐rFVIII‐FS reconstituted with 22.1 mg/kg of pegylated liposomes
Number of subjects: 16

Group type: COMPARATOR
Intervention: rFVIII‐FS (control)
Number of subjects: 16
Study: 15998278

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment with adjunctive doxycycline (100 mg/day for 15 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-surgical periodontal treatment without doxycycline
Number of subjects: 60
Study: 12706919

Group type: EXPERIMENTAL
Intervention: B-type natriuretic peptide (BNP) >80 pg/ml
Number of subjects: 1676

Group type: COMPARATOR
Intervention: B-type natriuretic peptide (BNP)
Number of subjects: 1676
Study: 11741217

Group type: EXPERIMENTAL
Intervention: nucleoside + lamivudine + nevirapine
Number of subjects: 100

Group type: COMPARATOR
Intervention: nucleoside + lamivudine + cotrimoxazole
Number of subjects: 100
Study: 8829881

Group type: EXPERIMENTAL
Intervention: Maximum voluntary eccentric muscle actions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Superimposed electrical stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Measures of arm circumference and ability to fully flex the elbow
Number of subjects: 30
Study: 1944976

Group type: EXPERIMENTAL
Intervention: Postoperative anti-platelet therapy with ASA and dipyridamole
Number of subjects: 15

Group type: COMPARATOR
Intervention: Postoperative anti-platelet therapy with indobufene
Number of subjects: 15
Study: 6365463

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Indoramin
Number of subjects: 50
Study: 31868691

Group type: EXPERIMENTAL
Intervention: Intensified nonverbal facilitation of swallowing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Basic care of the face and mouth plus treatment as usual
Number of subjects: 10
Study: 28586638

Group type: EXPERIMENTAL
Intervention: Paracetamol 1,000 mg, Ibuprofen 400 mg, Codeine 60 mg
Number of subjects: 131

Group type: COMPARATOR
Intervention: Paracetamol 1,000 mg, Ibuprofen 400 mg
Number of subjects: 131
Study: 27117850

Group type: EXPERIMENTAL
Intervention: 200 kcal meal (extremely hypocaloric)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 400 kcal meal (moderately hypocaloric)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 800 kcal meal (normocaloric)
Number of subjects: 10
Study: 24569618

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily for 12 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg daily for 12 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 22947332

Group type: EXPERIMENTAL
Intervention: Invitation letter with £45 vouchers for receiving three vaccinations
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard vaccination invitation letter
Number of subjects: 1000
Study: 19249034

Group type: EXPERIMENTAL
Intervention: Autologous endometrial coculture during ART cycles
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional ART cycles
Number of subjects: 68
Study: 17055685

Group type: EXPERIMENTAL
Intervention: Doxazosin mesylate (4 mg single dose)
Number of subjects: 12
Study: 15727589

Group type: EXPERIMENTAL
Intervention: Active nasal filters
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo nasal filters
Number of subjects: 46
Study: 12173810

Group type: EXPERIMENTAL
Intervention: Epidural analgesia plus temporary, intraoperative intercostal nerve blockade using 0.25% bupivacaine (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural analgesia only (group A)
Number of subjects: 40
Study: 9698717

Group type: EXPERIMENTAL
Intervention: Mebendazole 500 mg single-dose treatment
Number of subjects: 96

Group type: COMPARATOR
Intervention: Albendazole 400 mg single-dose treatment
Number of subjects: 96
Study: 8550163

Group type: EXPERIMENTAL
Intervention: Prefabricated functional brace
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional plaster treatment
Number of subjects: 85
Study: 3328986

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (40 mg daily for 2 years)
Number of subjects: 1407
Study: 29795665

Group type: EXPERIMENTAL
Intervention: Accurate-Pain-Reporting-Training (APRT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No-Training (Control)
Number of subjects: 51
Study: 27418444

Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: Risk score for nonresponse to 17-alpha hydroxyprogesterone caproate
Number of subjects: 754
Study: 24034864

Group type: EXPERIMENTAL
Intervention: Dental hygiene care programme using flash-based video, brochures, and toothpick method
Number of subjects: 73
Study: 22850734

Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 20889882

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP) among breastfeeding children
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP) among non-breastfeeding children
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Age less than 18 months (independent of treatment)
Number of subjects: 468
Study: 18950305

Group type: EXPERIMENTAL
Intervention: AC on (automatic capture)
Number of subjects: 910

Group type: COMPARATOR
Intervention: AC off (standard programming)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: AC on
Number of subjects: 910
Study: 19439966

Group type: EXPERIMENTAL
Intervention: 2.3 g omega-3 fatty acids daily for 6 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 15057894

Group type: EXPERIMENTAL
Intervention: Colchicine plus UDCA
Number of subjects: 85

Group type: COMPARATOR
Intervention: Methotrexate plus UDCA
Number of subjects: 85
Study: 11694151

Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy (n = 1222)
Number of subjects: 3489

Group type: COMPARATOR
Intervention: Noninvasive treatment strategy (n = 1235)
Number of subjects: 3489

Group type: COMPARATOR
Intervention: Placebo (n = 1127)
Number of subjects: 3489

Group type: EXPERIMENTAL
Intervention: Dalteparin (n = 1140)
Number of subjects: 3489
Study: 9414055

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Controlled-release morphine
Number of subjects: 45
Study: 8275889

Group type: EXPERIMENTAL
Intervention: Phenothiazine (chlorpromazine 350 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Butyrophenone (haloperidol 15 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Haloperidol 30 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anticholinergic agents (trihexiphenidyl, 5 mg)
Number of subjects: 30
Study: 2827044

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg once daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diltiazem (120 mg twice daily)
Number of subjects: 16
Study: 11257242

Group type: EXPERIMENTAL
Intervention: DSG-OC
Number of subjects: 66

Group type: COMPARATOR
Intervention: LNG-OC
Number of subjects: 66
Study: 31077604

Group type: EXPERIMENTAL
Intervention: Living with dogs
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Each additional dog owned
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Infants living with at least two dogs
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Owning dogs or cats
Number of subjects: 1124
Study: 29072362

Group type: EXPERIMENTAL
Intervention: Nurse-led care (NLC)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Rheumatologist-led care (RLC)
Number of subjects: 214
Study: 26998961

Group type: EXPERIMENTAL
Intervention: Teach-to-goal instruction
Number of subjects: 120

Group type: COMPARATOR
Intervention: Brief verbal instruction
Number of subjects: 120
Study: 25012432

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 22743314

Group type: EXPERIMENTAL
Intervention: Inulin (20 g/d, 3 times/d for 4 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (3 times/d for 4 weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inulin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 19647945

Group type: EXPERIMENTAL
Intervention: Ghrelin (50 microg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17373724

Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine withdrawal for 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0
Study: 14694237

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation with vitamins C and E
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 12382087

Group type: EXPERIMENTAL
Intervention: 0.1% octenidine dihydrochloride with 30% 1‐propanol and 45% 2‐propanol
Number of subjects: 60

Group type: COMPARATOR
Intervention: 74% ethanol with 10% 2‐propanol
Number of subjects: 60
Study: 9689291

Group type: EXPERIMENTAL
Intervention: Laser Doppler Imaging (LDI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Passive dependency posture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical application of methyl nicotinate (vasodilator)
Number of subjects: 0
Study: 8136665

Group type: EXPERIMENTAL
Intervention: Electronic monitoring
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Pinard stethoscope by research midwife
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Routine use of Pinard stethoscope by attending midwife
Number of subjects: 1255
Study: 2686425

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin (200 mg every 12 hours, plus a daily extra placebo dose)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intravenous ceftazidime (1 g every eight hours)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 59
Study: 30266711

Group type: EXPERIMENTAL
Intervention: S1 pedicle screw with PMMA augmentation (group A)
Number of subjects: 75

Group type: COMPARATOR
Intervention: S1 bicortical pedicle screw fixation (group B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: S1 tricortical pedicle screw fixation (group C)
Number of subjects: 75
Study: 28225052

Group type: EXPERIMENTAL
Intervention: Behavioral modification and nutritional education (BM-NE) intervention
Number of subjects: 139

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 139
Study: 25925801

Group type: EXPERIMENTAL
Intervention: Web-based intervention ('breakingtheice')
Number of subjects: 160

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 160
Study: 23270788

Group type: EXPERIMENTAL
Intervention: Anteromedial portal technique (AMP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transtibial technique
Number of subjects: 50
Study: 21205384

Group type: EXPERIMENTAL
Intervention: Exercise and placebo (Ex+PLA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Isoflavones (ISO)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Exercise and isoflavones (Ex+ISO)
Number of subjects: 100
Study: 18753809

Group type: EXPERIMENTAL
Intervention: Quality of sleep, depression, late-life function and disability assessment
Number of subjects: 128
Study: 16613341

Group type: EXPERIMENTAL
Intervention: Men with a history of sexually transmitted infections
Number of subjects: 39

Group type: COMPARATOR
Intervention: Men without a history of sexually transmitted infections
Number of subjects: 39
Study: 14600814

Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 520

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 520
Study: 10479237

Group type: EXPERIMENTAL
Intervention: Fasting for 7-10 days followed by an individually adjusted, gluten-free, vegan diet for 3.5 months and then an individually adjusted lactovegetarian diet for 9 months
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group following their usual omnivorous diet
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Vegetarian diet responders
Number of subjects: 53

Group type: COMPARATOR
Intervention: Diet nonresponders and omnivores
Number of subjects: 53
Study: 8566592

Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acid suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of H. pylori eradication and acid suppression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ulcer healing
Number of subjects: 0
Study: 1937545

Group type: EXPERIMENTAL
Intervention: MCP plus oral lorazepam (1 mg/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: MCP (0.5 mg/kg 6 hourly i.v.)
Number of subjects: 25
Study: 7035638

Group type: EXPERIMENTAL
Intervention: Intravenous alimentation with a solution containing carbohydrate as 50% glucose and 50% galactose
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control glucose period
Number of subjects: 6
Study: 30408596

Group type: EXPERIMENTAL
Intervention: Real neurofeedback (n=25) with Amyg-EFP-neurofeedback sessions for five weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Real neurofeedback (n=25)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham neurofeedback (n=9)
Number of subjects: 34
Study: 27931142

Group type: EXPERIMENTAL
Intervention: Orafti® inulin‐type fructans (2g daily for 6 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 22
Study: 27387121

Group type: EXPERIMENTAL
Intervention: Stories intervention (viewing videos of African-American Veterans telling stories about successful hypertension management)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Stories intervention
Number of subjects: 618
Study: 25091463

Group type: EXPERIMENTAL
Intervention: Rigid orthotic
Number of subjects: 56

Group type: COMPARATOR
Intervention: Semi-rigid orthotic
Number of subjects: 56
Study: 21735216

Group type: EXPERIMENTAL
Intervention: 100 m sprint
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 200 m sprint
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 400 m sprint
Number of subjects: 11
Study: 19777799

Group type: EXPERIMENTAL
Intervention: Arginine supplementation at 0.1 g/kg‐wt
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17907864

Group type: EXPERIMENTAL
Intervention: Group Motivational Interviewing (GMI)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Therapist Attention Activity Control Group (TAAC)
Number of subjects: 101
Study: 14987460

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (n = 41, cooled to 32-33 degrees C for 24 or 48 hours)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 68
Study: 11407108

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparins
Number of subjects: 0
Study: 9313596

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 763
Study: 8198055

Group type: EXPERIMENTAL
Intervention: MUFA-diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: SAFA-diet
Number of subjects: 0
Study: 3067410

Group type: EXPERIMENTAL
Intervention: Allapinin
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Ethacizine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Mexitil
Number of subjects: 33
Study: 31075706

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT), 12 sessions
Number of subjects: 137
Study: 28162849

Group type: EXPERIMENTAL
Intervention: Brief feedback version of Grassessment
Number of subjects: 287

Group type: COMPARATOR
Intervention: Extended feedback version of Grassessment
Number of subjects: 287
Study: 25491929

Group type: EXPERIMENTAL
Intervention: 7 mg nicotine patch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 20
Study: 23656707

Group type: EXPERIMENTAL
Intervention: Oral glucose (50 g available carbohydrate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: White bread (50 g available carbohydrate)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both oral glucose and white bread
Number of subjects: 20
Study: 21942436

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg oral daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19127191

Group type: EXPERIMENTAL
Intervention: Sports club participation (SCP) defined as participation at least once a week
Number of subjects: 502

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 502
Study: 16895950

Group type: COMPARATOR
Intervention: T+DMPA (testosterone implant + depot medroxy progesterone acetate)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: T+DMPA+FSH (testosterone implant + depot medroxy progesterone acetate + follicle-stimulating hormone)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: T+DMPA+hCG (testosterone implant + depot medroxy progesterone acetate + human chorionic gonadotropin)
Number of subjects: 18
Study: 15204675

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone taper regimen for short-term opioid detoxification
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone taper regimen
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone
Number of subjects: 234
Study: 11556635

Group type: EXPERIMENTAL
Intervention: Mecamylamine (2.5 to 7.5 mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9260216

Group type: EXPERIMENTAL
Intervention: Training program for standardizing SCORAD scoring by non-expert investigators
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Dermatologically experienced physicians
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Non-dermatologically experienced physicians
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Training program for standardizing SCORAD scoring
Number of subjects: 817
Study: 8498652

Group type: EXPERIMENTAL
Intervention: Propofol (Groups 3 and 4)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Thiopental and enflurane (Group 1)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine and succinylcholine (Group 2)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Atracurium (Group 5)
Number of subjects: 155
Study: 3027905

Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lisinopril plus Hydrochlorothiazide (HCTZ)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Atenolol plus Hydrochlorothiazide (HCTZ)
Number of subjects: 24
Study: 2688075

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 30389316

Group type: EXPERIMENTAL
Intervention: Teachable Moment Brief Intervention (TMBI) + Care as Usual (CAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teachable Moment Brief Intervention (TMBI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 0
Study: 31581743

Group type: EXPERIMENTAL
Intervention: High green leafy vegetable (GLV) dietary intervention, one cooked cup equivalent daily for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control period (delayed intervention)
Number of subjects: 50